Literature DB >> 30025922

Prevalence of and Risk Factors for Colorectal Neoplasia in Asymptomatic Young Adults (20-39 Years Old).

Nam Hee Kim1, Yoon Suk Jung2, Hyo-Joon Yang3, Soo-Kyung Park3, Jung Ho Park3, Dong Il Park3, Chong Il Sohn3.   

Abstract

BACKGROUND & AIMS: The incidence of colorectal cancer is increasing among persons 50 years old or younger. However, data on the epidemiology of young-onset colorectal neoplasia (CRN) are limited. Although some studies have investigated the epidemiology of CRN in persons younger than 50 years, most have focused on persons 40 years or older. We evaluated the prevalence of and risk factors for CRN in adults younger than 40 years.
METHODS: We performed a cross-sectional analysis of 72,356 asymptomatic individuals, 20-39 years old, who underwent colonoscopies as participants in the Kangbuk Samsung Health Study in South Korea, from August 2004 through December 2015. Data on medical history and health-related behavior were collected from self-administered questionnaires. Patients were divided into groups based on age (20-29 years, n = 7340 or 30-39 years, n = 65,016), and χ2 tests were used to compare categorical variables between groups. A multivariate logistic regression model was used to assess the risk factors for overall and advanced CRN.
RESULTS: The prevalence of overall CRN in group of 20-29 years was 5.9% and in the group of 30-39 years was 9.5% (P < .001); prevalence values for advanced CRN were 0.6% and 0.9%, respectively (P = .005). In the group of 30-39 years, age, smoking, alcohol intake, obesity, and abdominal obesity were independent risk factors for overall and advanced CRN. Additionally, male sex and metabolic syndrome were independent risk factors for overall CRN, whereas regular exercise reduced risk of overall CRN. Even in the 20-29 years group, obesity, abdominal obesity, and increased levels of triglycerides were independent risk factors for overall and advanced CRN, whereas age, increased blood pressure, and increased fasting blood glucose level were independent risk factors for overall CRN.
CONCLUSION: In a retrospective analysis of 72,356 asymptomatic persons under 40 years of age evaluated by colonoscopy in Korea, we found modifiable factors, such as smoking, alcohol intake, obesity, and metabolic syndrome, to be significant risk factors for CRN-even in persons of 20-39 years old. Colorectal cancer screening strategies should consider these risk factors.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRC; Colon Cancer; Endoscopy; Epidemiology

Year:  2018        PMID: 30025922     DOI: 10.1016/j.cgh.2018.07.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  19 in total

1.  Risk Factors for Early-Onset Colorectal Cancer.

Authors:  Eric E Low; Joshua Demb; Lin Liu; Ashley Earles; Ranier Bustamante; Christina D Williams; Dawn Provenzale; Tonya Kaltenbach; Andrew J Gawron; Maria Elena Martinez; Samir Gupta
Journal:  Gastroenterology       Date:  2020-01-09       Impact factor: 22.682

Review 2.  Colorectal Cancer in Young Adults.

Authors:  Anand Venugopal; Elena M Stoffel
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

3.  Colorectal Cancer in the Adolescent and Young Adult Population.

Authors:  Y Nancy You; Lucas D Lee; Benjamin W Deschner; David Shibata
Journal:  JCO Oncol Pract       Date:  2020-01

Review 4.  Is early-onset cancer an emerging global epidemic? Current evidence and future implications.

Authors:  Tomotaka Ugai; Naoko Sasamoto; Hwa-Young Lee; Mariko Ando; Mingyang Song; Rulla M Tamimi; Ichiro Kawachi; Peter T Campbell; Edward L Giovannucci; Elisabete Weiderpass; Timothy R Rebbeck; Shuji Ogino
Journal:  Nat Rev Clin Oncol       Date:  2022-09-06       Impact factor: 65.011

Review 5.  Colorectal Cancer in Younger Adults.

Authors:  Pooja Dharwadkar; Timothy A Zaki; Caitlin C Murphy
Journal:  Hematol Oncol Clin North Am       Date:  2022-05-13       Impact factor: 2.861

6.  Young-Onset Gastrointestinal Adenocarcinoma Incidence and Survival Trends in the Northern Territory, Australia, with Emphasis on Indigenous Peoples.

Authors:  Mia Shepherdson; Shalem Leemaqz; Gurmeet Singh; Courtney Ryder; Shahid Ullah; Karla Canuto; Joanne P Young; Timothy J Price; Ross A McKinnon; Stephen J Pandol; Claire T Roberts; Savio George Barreto
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

7.  Colorectal cancer risk based on extended family history and body mass index.

Authors:  Heather M Ochs-Balcom; Priyanka Kanth; James M Farnham; Samir Abdelrahman; Lisa A Cannon-Albright
Journal:  Genet Epidemiol       Date:  2020-07-16       Impact factor: 2.135

Review 8.  An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer.

Authors:  Andrea N Burnett-Hartman; Jeffrey K Lee; Joshua Demb; Samir Gupta
Journal:  Gastroenterology       Date:  2021-01-05       Impact factor: 22.682

Review 9.  Rising incidence of early-onset colorectal cancer - a call to action.

Authors:  Naohiko Akimoto; Tomotaka Ugai; Rong Zhong; Tsuyoshi Hamada; Kenji Fujiyoshi; Marios Giannakis; Kana Wu; Yin Cao; Kimmie Ng; Shuji Ogino
Journal:  Nat Rev Clin Oncol       Date:  2020-11-20       Impact factor: 66.675

10.  Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer.

Authors:  Alexi N Archambault; Yi Lin; Jihyoun Jeon; Tabitha A Harrison; D Timothy Bishop; Hermann Brenner; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Jane C Figueiredo; Steven Gallinger; Stephen B Gruber; Marc J Gunter; Michael Hoffmeister; Mark A Jenkins; Temitope O Keku; Loïc Le Marchand; Li Li; Victor Moreno; Polly A Newcomb; Rish Pai; Patrick S Parfrey; Gad Rennert; Lori C Sakoda; Robert S Sandler; Martha L Slattery; Mingyang Song; Aung Ko Win; Michael O Woods; Neil Murphy; Peter T Campbell; Yu-Ru Su; Anne Zeleniuch-Jacquotte; Peter S Liang; Mengmeng Du; Li Hsu; Ulrike Peters; Richard B Hayes
Journal:  JNCI Cancer Spectr       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.